Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Wesley H. Clark, Caitlin S. Shannon, Beverly Winikoff
Abstract
Wesley H. Clark, Caitlin S. Shannon, Beverly Winikoff
Abstract
Misoprostol – a drug developed and approved originally for the prevention of gastric ulcers – has shown itself to be safe, effective and acceptable for uterine evacuation in the context of induced abortion and failed pregnancy. Many practitioners consider it to be the treatment of choice for these indications, despite the fact that, as of now, nearly all such use remains off-label. In the absence of regulatory guidelines, a great deal of research on misoprostol for uterine evacuation has been conducted – research that both suggests desirable approaches to treatment and highlights areas of continuing uncertainty. It is hoped that summarizing these data can both assist practitioners in their work and spur movement towards optimized regimens and the eventual registration of misoprostol for these uses.
OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Misoprostol – a drug developed and approved originally for the prevention of gastric ulcers – has shown itself to be safe, effective and acceptable for uterine evacuation in the context of induced abortion and failed pregnancy. Many practitioners consider it to be the treatment of choice for these indications, despite the fact that, as of now, nearly all such use remains off-label. In the absence of regulatory guidelines, a great deal of research on misoprostol for uterine evacuation has been conducted – research that both suggests desirable approaches to treatment and highlights areas of continuing uncertainty. It is hoped that summarizing these data can both assist practitioners in their work and spur movement towards optimized regimens and the eventual registration of misoprostol for these uses.
Key concepts: Misoprostol, Medicine, Context (archaeology), Abortion, Pregnancy, Obstetrics, Gynecology, Intensive care medicine